Statistical Analysis
Cancer
CANCER
This study evaluated the safety and tolerability of ficlatuzumab when given with standard chemotherapy with the aim of determining the maximum tolerated dose (MTD) of ficlatuzumab in combination with gemcitabine and The study (NCT03316599) was approved by the Dana-Farber Cancer Institute institutional review board and conducted in accordance with the Declaration of Helsinki. All patients provided written informed consent before any study procedures.